Sodium-glucose cotransporter inhibitors as add-on therapy in addition to insulin for type 1 diabetes mellitus: A meta-analysis of randomized controlled trials.
Hailan ZouLili LiuJia GuoHongjuan WangSiyun LiuYixuan XingChao DengYang XiaoZhiguang ZhouPublished in: Journal of diabetes investigation (2020)
SGLT2 and SGLT1/2 inhibitors can improve glycemic control in patients with type 1 diabetes.